IRCT2012091510842N1已完成4 期
Comparison of efficacy and safety of oral itraconazole with placebo in the primary treatment and maintenance therapy of moderate to severe seborrheic dermatitis.
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 68
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 70 years（—）
- 性别
- All
入选标准
- •Moderate to severe seborrheic dermatitis that will be diagnosed clinically by a dermatologist +/- Recurrent seborrheic dermatitis +/- Seborrheic dermatitis resistant to Topical therapy; Age =18; Patients willing to take part in the study and expected to be available for the duration of study and comply with study visits. Exclusion criteria: Seborrheic Dermatitis(SD) associated with any other papulosquamous dermatoses like psoriasis, rosacea, lupus erythematous, lichen planus, tinea, and eczema; Significant renal or liver disease; AIDS; Parkinson Disease; Allergy to azoles; Drug use interfering with itraconazole; Very severe dermatitis defined by erythrodermia or extensive flexural involvement; Use of topical therapy (except moisturizers) and systemic therapy in last 2 week and 1 month, respectively; Pregnancy and lactation.
排除标准
- 未提供
研究者
相似试验
已完成
Unknown
Comparing two anti-fungal drug combination in the treatment of fungal infection.CTRI/2023/11/059827meenakshi medical college hospital and research institute100
尚未招募
Unknown
In patients of a fungal skin problem called superficial dermatophytosis which is better among Itraconazole and Itraconazole with Isotretnoin?CTRI/2024/07/071678Bhagat Phool Singh Govt. Medical College
进行中（未招募）
1 期
Itraconazole as treatment for severe nose bleeding in patients with hereditary hemorrhagic telangiectasiaSevere epistaxis in patients with Hereditary Hemorrhagic Telangiectasia also known as Rendu-Osler-Weber diseaseMedDRA version: 20.0Level: LLTClassification code 10031132Term: Osler-Weber-Rendu diseaseSystem Organ Class: 100000004850MedDRA version: 20.0Level: LLTClassification code 10038554Term: Rendu-Osler-Weber syndromeSystem Organ Class: 100000004850EUCTR2017-003272-31-NLSt. Antonius Ziekenhuis25
已完成
2 期
Efficacy and safety of oral itraconazole in the reduction of epistaxis severity in hereditary hemorrhagic telangiectasiahereditary hemorrhagic telangiectasiaRendu-Osler-Weber disease100075101004704310047075NL-OMON46365Sint Antonius Ziekenhuis25
尚未招募
3 期
A comparative study between oral itraconazole and terbinafine in tinea infectioCTRI/2023/10/058844Mahatma Gandhi Hospital